USPTO serial 97724128
PALDRONABOL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BECKER, JOSEPH RAPHAEL
- Law office
- LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PALDRONABOL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael G Shariff
MICHAEL G SHARIFF INVENTA CAPITAL PLC40900 WOODWARD AVENUE, SUITE 111BLOOMFIELD HILLS, MI 48304UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Drug discovery services for alleviating the symptoms of Parkinsonism/ Parkinson's disease; Pharmaceutical research services; Research on the subject of pharmaceuticals for alleviating the symptoms of Parkinsonism/ Parkinson's disease; Technical research in the field of pharmaceutical studies; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics for alleviating the symptoms of Parkinsonism/ Parkinson's disease ; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials for alleviating the symptoms of Parkinsonism/ Parkinson's disease; Development of pharmaceutical preparations and medicines for alleviating the symptoms of Parkinsonism/ Parkinson's disease; Development of pharmaceutical preparations, used internally as pills and other solids, and also used as sprays and liquids, for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Pharmaceutical product evaluation, scientific and technological services and research and design services relating thereto, namely, scientific research, research and design in the fields of pharmaceuticals, agrochemicals, bioactive compounds, fine chemicals, chemical feed stocks, polymers, paints, dyestuffs, adhesives, material sciences, engineering, nanomaterials, and foodstuffs; Chemical research; Chemical research, namely, chemical technological research; Chemical analysis; Chemistry services, namely, chemistry research, laboratory research in the field of chemistry; Chemistry consultation; Scientific research relating to chemistry for alleviating the symptoms of Parkinsonism/ Parkinson's disease; Research and development services in the field of chemistry for alleviating the symptoms of Parkinsonism/ Parkinson's disease; Design and development of chemical compounds; Design and development of synthetic chemical compounds; Rental of laboratory apparatus and instruments for alleviating the symptoms of Parkinsonism/ Parkinson's disease | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 13, 2023 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 13, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 13, 2023 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 30, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 30, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 30, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 30, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 17, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 22, 2022 | NWAP | NEW APPLICATION ENTERED | — |